Home › Funds › Farallon Capital Management › BEAM
Farallon Capital Management position in BEAM
BEAM THERAPEUTICS INC · Health Care
Farallon Capital Management reported holding 10,276,396 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$251.3M, representing 1.11% of its reported portfolio and ranking #26 among its reported holdings. Farallon Capital Management has disclosed BEAM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Farallon Capital Management's BEAM position evolved
Farallon Capital Management first disclosed a stake in BEAM in Q3 2021 at 1,717,590 shares (US$149.4M). The position peaked in Q2 2026 at 10,236,396 shares, worth US$351.3M. Across 21 filings, Farallon Capital Management increased the stake 13 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 10,276,396 shares valued at US$251.3M. Notable position changes include a 32% increase in Q4 2021 (shares fell 27% over the following quarter), a 34% increase in Q2 2022 (shares rose 22% over the following quarter), a 75% increase in Q2 2024 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.72M | $149.45M | New |
| Q4 2021 | 2.27M | $180.50M | Add |
| Q1 2022 | 2.59M | $148.66M | Add |
| Q2 2022 | 3.47M | $134.41M | Add |
| Q3 2022 | 3.63M | $172.99M | Add |
| Q4 2022 | 3.40M | $132.97M | Reduce |
| Q1 2023 | 3.43M | $105.09M | Add |
| Q2 2023 | 3.44M | $109.89M | Hold |
| Q3 2023 | 4.48M | $107.79M | Add |
| Q4 2023 | 4.11M | $111.76M | Reduce |
| Q1 2024 | 4.51M | $149.07M | Add |
| Q2 2024 | 7.91M | $185.40M | Add |
| Q3 2024 | 8.21M | $201.10M | Add |
| Q4 2024 | 8.24M | $204.33M | Hold |
| Q1 2025 | 9.93M | $193.90M | Add |
| Q2 2025 | 10.01M | $170.32M | Add |
| Q3 2025 | 10.06M | $244.23M | Hold |
| Q4 2025 | 10.06M | $278.95M | Hold |
| Q1 2026 | 10.13M | $241.51M | Add |
| Q2 2026 | 10.24M | $351.31M | Add |
| Q3 2026 | 10.28M | $251.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BEAM and 13F data
BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in BEAM — the largest reported positions include ARK Invest (US$288.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$251.3M), ARCH Venture Management, LLC (US$111.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BEAM
- ARK Invest 11.81M sh · $288.64M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.28M sh · $251.26M · Q3 2026
- ARCH Venture Management, LLC 4.54M sh · $111.01M · Q3 2026
- Kynam Capital Management, LP 3.93M sh · $96.18M · Q3 2026
- Amova Asset Management Americas, Inc. 3.35M sh · $81.76M · Q3 2026
- Casdin Capital 1.50M sh · $36.67M · Q3 2026
- Redmile Group, LLC 1.06M sh · $25.96M · Q3 2026
More on Farallon Capital Management
FAQ
How long has Farallon Capital Management held BEAM?
Farallon Capital Management has disclosed BEAM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Farallon Capital Management's current position in BEAM?
As of Q3 2026, Farallon Capital Management holds 10.28M shares of BEAM (BEAM THERAPEUTICS INC), valued at $251.26M, representing 1.11% of its reported portfolio and ranking #26.
Has Farallon Capital Management been buying or selling BEAM?
In the latest 13F filing (Q3 2026), Farallon Capital Management held unchanged its position in BEAM. The position peaked in Q2 2026 at 10.24M shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include ARK Invest, FARALLON CAPITAL MANAGEMENT, L.L.C., ARCH Venture Management, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.